SEC Tracker
Get the app

AVROBIO TECX

AVROBIO, Inc. held its previously announced 2022 Annual Meeting of Stockholders

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
Exhibit 10.1
Material contract
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when AVROBIO files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  2. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  3. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  4. Lifecore Biomedical LFCR public float $223M, Jun 30, 2025
  5. Annexon ANNX public float $244M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.